Pheochromocytoma is one of the most life-threatening endocrine disorders as a consequence of complications arising from hemodynamic instability associated with tumoral secretion of catecholamines.

Patients diagnosed with pheochromocytoma or paraganglioma, tumors that form within certain endocrine tissues, such as the adrenal glands, may have abnormal endocrine activity due to the synthesis ...

The 2004 WHO classification of endocrine tumors defines pheochromocytoma as a tumor arising from catecholamine-producing chromaffin cells in the adrenal medulla -- an intra-adrenal paraganglioma.

Multiple endocrine neoplasia (MEN) describes a group of rare genetic disorders that affect ... MEN type 2A can cause medullary thyroid cancer, hyperparathyroidism, and pheochromocytoma. MEN type 2B is ...

1 “Pheochromocytoma and paraganglioma are rare tumors that form in and around the ... They are also common in people with inherited disorders such as VHL, Carney-Stratakis syndrome, and certain types ...

As board-certified, fellowship-trained endocrine surgeons, they offer specialized care to patients in Houston and the surrounding area, with thyroid nodules, goiter, Graves’ disease, thyroid cancer, ...

The US Food and Drug Administration (FDA) will soon decide on whether to expand the label of MSD’s Welireg (belzutifan) to include its use for the treatment of the rare cancer pheochromocytoma ...

Schiff RA, Welsh GA: Perioperative evaluation and mangement of the patient with endocrine dysfunction ... Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection.